Jian Hao

714 total citations
25 papers, 533 citations indexed

About

Jian Hao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jian Hao has authored 25 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Jian Hao's work include Bioactive Compounds and Antitumor Agents (3 papers), Pharmacological Effects of Natural Compounds (3 papers) and Computational Drug Discovery Methods (3 papers). Jian Hao is often cited by papers focused on Bioactive Compounds and Antitumor Agents (3 papers), Pharmacological Effects of Natural Compounds (3 papers) and Computational Drug Discovery Methods (3 papers). Jian Hao collaborates with scholars based in China, United States and Germany. Jian Hao's co-authors include Xiong-Zhi Wu, Xue Yang, Cui-Hong Zhu, Yangyang Niu, Xiuli Ding, Chang Liu, Dan Liu, Yu Mao, Rui Cao and Ziqi Jin and has published in prestigious journals such as Scientific Reports, Brain Research and Medicine.

In The Last Decade

Jian Hao

24 papers receiving 525 citations

Peers

Jian Hao

ONCOL

PHARM

CAM

Ziqi Meng China

Shuyu Liu China

Wu-Ming Qin China

Siyu Guo China

Lijing Jiao China

Mianhua Wu China

Xinxing Lai China

Xiyang Tang China

Dazhi Sun China

Namrata Rastogi India

Ziqi Meng China

Jian Hao

378 ×1.5

99 ×0.8

ONCOL

90 ×0.9

PHARM

149 ×2.0

49 ×0.8

CAM

Citations per year, relative to Jian Hao Jian Hao (= 1×) peers Ziqi Meng

Countries citing papers authored by Jian Hao

Since Specialization

Citations

This map shows the geographic impact of Jian Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Hao more than expected).

Fields of papers citing papers by Jian Hao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Hao. The network helps show where Jian Hao may publish in the future.

Co-authorship network of co-authors of Jian Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Jian Hao. A scholar is included among the top collaborators of Jian Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian Hao. Jian Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hao, Jian, Li Xie, Zhenhan Li, et al.. (2025). Actl6a regulates autophagy via Sox2-dependent Atg5 and Atg7 expression to inhibit apoptosis in spinal cord injury. Journal of Advanced Research. 77. 281–296.

Li, Xueqi, et al.. (2025). Obinutuzumab is Effective as an Initial Treatment for PLA2R-Associated Primary Membranous Nephropathy: A Retrospective, Single-Center Trial. Drug Design Development and Therapy. Volume 19. 5961–5972. 1 indexed citations

Zhong, Yue, et al.. (2025). Peritoneal dialysis-associated peritonitis caused by Coxiella Burnetii: A case report. Medicine. 104(5). e41407–e41407. 1 indexed citations

Hao, Jian, Zhenhan Li, Bingbing Yu, et al.. (2023). Syringaresinol promotes the recovery of spinal cord injury by inhibiting neuron apoptosis via activating the ubiquitination factor E4B/AKT Serine/Threonine kinase signal pathway. Brain Research. 1824. 148684–148684. 4 indexed citations

Zhang, Chang, et al.. (2022). Tanshinone IIA promotes apoptosis by downregulating BCL2 and upregulating TP53 in triple-negative breast cancer. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(2). 365–374. 9 indexed citations

Hao, Jian, et al.. (2021). Network pharmacology-based and clinically relevant prediction of active ingredients and potential targets of Chinese herbs on stage IV lung adenocarcinoma patients. Journal of Cancer Research and Clinical Oncology. 147(7). 2079–2092. 5 indexed citations

Hao, Jian, et al.. (2020). Network Pharmacology‐Based Strategy for Predicting Therapy Targets of Traditional Chinese Medicine Xihuang Pill on Liver Cancer. Evidence-based Complementary and Alternative Medicine. 2020(1). 6076572–6076572. 11 indexed citations

Hao, Jian, et al.. (2019). Effects of the proteasome inhibitor bortezomib in combination with chemotherapy for the treatment of mantle cell lymphoma: a meta-analysis. Turkish Journal of Hematology. 37(1). 13–19. 3 indexed citations

Yang, Xue, Cui-Hong Zhu, Rui Cao, Jian Hao, & Xiong-Zhi Wu. (2018). Sublingual Nodules: Diagnostic Markers of Metastatic Breast Cancer. Chinese Journal of Integrative Medicine. 24(10). 741–745. 3 indexed citations

10.

Hao, Jian, Ziqi Jin, Xiaohui Liu, et al.. (2018). Antiestrogenic Activity of the Xi-Huang Formula for Breast Cancer by Targeting the Estrogen Receptor α. Cellular Physiology and Biochemistry. 47(6). 2199–2215. 16 indexed citations

11.

Hao, Jian, et al.. (2018). Molecular targets of Chinese herbs: a clinical study of metastatic colorectal cancer based on network pharmacology. Scientific Reports. 8(1). 7238–7238. 26 indexed citations

12.

Jin, Ziqi, Jian Hao, Xue Yang, et al.. (2018). Higenamine enhances the antitumor effects of cucurbitacin B in breast cancer by inhibiting the interaction of AKT and CDK2. Oncology Reports. 40(4). 2127–2136. 16 indexed citations

13.

Gao, Li, Xiaodong Wang, Yangyang Niu, et al.. (2016). Molecular targets of Chinese herbs: a clinical study of hepatoma based on network pharmacology. Scientific Reports. 6(1). 24944–24944. 75 indexed citations

14.

Yang, Xue, Jian Hao, Yu Mao, et al.. (2016). bFGF Promotes Migration and Induces Cancer-Associated Fibroblast Differentiation of Mouse Bone Mesenchymal Stem Cells to Promote Tumor Growth. Stem Cells and Development. 25(21). 1629–1639. 33 indexed citations

15.

Li, Ying, et al.. (2016). Effects of Statins on Bone Mineral Density and Fracture Risk. Medicine. 95(22). e3042–e3042. 53 indexed citations

16.

Hao, Jian, Xiuli Ding, Xue Yang, & Xiong-Zhi Wu. (2016). Prunella vulgaris Polysaccharide Inhibits Growth and Migration of Breast Carcinoma-Associated Fibroblasts by Suppressing Expression of Basic Fibroblast Growth Factor. Chinese Journal of Integrative Medicine. 26(4). 270–276. 22 indexed citations

17.

Gao, Li, Jian Hao, Yangyang Niu, et al.. (2016). Network pharmacology dissection of multiscale mechanisms of herbal medicines in stage IV gastric adenocarcinoma treatment. Medicine. 95(35). e4389–e4389. 21 indexed citations

18.

Hao, Jian, Xue Yang, Xiuli Ding, et al.. (2016). Paeoniflorin Potentiates the Inhibitory Effects of Erlotinib in Pancreatic Cancer Cell Lines by Reducing ErbB3 Phosphorylation. Scientific Reports. 6(1). 32809–32809. 21 indexed citations

19.

Yang, Xue, Jian Hao, Cui-Hong Zhu, et al.. (2015). Survival Benefits of Western and Traditional Chinese Medicine Treatment for Patients With Pancreatic Cancer. Medicine. 94(26). e1008–e1008. 33 indexed citations

20.

Wang, Yanan, Jian Hao, Xiaohui Liu, et al.. (2014). Pretreatment Plasma D-Dimer, Fibrinogen, and Platelet Levels Significantly Impact Prognosis in Patients With Epithelial Ovarian Cancer Independently of Venous Thromboembolism. International Journal of Gynecological Cancer. 25(1). 23–31. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact